Tapewire

Nasdaq · USD

PCRX

Pacira BioSciences, Inc.

Export transactions ↓
Tapewire entity
4928
SEC CIK
0001396814
Parsed reports
428

Last 12 months

Inside the activity.

0 purchase rows · 17 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202601
Feb 202602
Mar 202602
Apr 202604
May 202600
Jun 202602
Jul 202600
Aug 202601
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 15, 2018 Filed Aug 16, 2018 17:14 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 610 $5.49 $3,348.90
Disclosure

SEC source: 0001209191-18-047110 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,264

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · balance_after: Includes 239 shares of common stock acquired under the issuer's employee stock purchase plan in June 2018.

Read SEC document
August 14, 2018 Filed Aug 16, 2018 21:12 UTC
WILLIAMS KRISTENCAO and General Counsel
SaleCommon Stock 4,773 $47.04 $224,521.92
Disclosure

SEC source: 0001209191-18-047108 · doc4.xml · nonDerivative · entry 1

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,374

F1 · kind: The sales reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.80 to $47.243, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:20 UTC
Scranton RichardChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 47,250 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038202 · doc4.xml · derivative · entry 2

Scranton Richard · CIK 0001709330 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,250

Underlying: Common Stock · 47,250 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:20 UTC
Scranton RichardChief Scientific Officer
GrantCommon Stock 7,875 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038202 · doc4.xml · nonDerivative · entry 1

Scranton Richard · CIK 0001709330 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,101

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:13 UTC GrantStock Option (Right to Buy) · Derivative 4,693 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038190 · doc4.xml · derivative · entry 2

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,693

Underlying: Common Stock · 4,693 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:13 UTC GrantCommon Stock 782 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038190 · doc4.xml · nonDerivative · entry 1

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 882

F1 · shares: Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:19 UTC
Reinhart Charles A. IIIChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038199 · doc4.xml · derivative · entry 2

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:19 UTC
Reinhart Charles A. IIIChief Financial Officer
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038199 · doc4.xml · nonDerivative · entry 1

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,042

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:13 UTC GrantStock Option (Right to Buy) · Derivative 4,693 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038191 · doc4.xml · derivative · entry 2

Greenstreet Yvonne · CIK 0001446125 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,693

Underlying: Common Stock · 4,693 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:13 UTC GrantCommon Stock 782 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038191 · doc4.xml · nonDerivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,627

F1 · shares: Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:21 UTC
WILLIAMS KRISTENCAO and General Counsel
GrantStock Option (Right to Buy) · Derivative 47,250 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038204 · doc4.xml · derivative · entry 2

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,250

Underlying: Common Stock · 47,250 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:21 UTC
WILLIAMS KRISTENCAO and General Counsel
GrantCommon Stock 7,875 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038204 · doc4.xml · nonDerivative · entry 1

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,147

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:16 UTC GrantStock Option (Right to Buy) · Derivative 4,693 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038196 · doc4.xml · derivative · entry 2

LONGENECKER JOHN P PHD · CIK 0001288231 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,693

Underlying: Common Stock · 4,693 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:16 UTC GrantCommon Stock 782 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038196 · doc4.xml · nonDerivative · entry 1

LONGENECKER JOHN P PHD · CIK 0001288231 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,927

F1 · shares: Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:21 UTC
STACK DAVID MDirector · CEO and Chairman
GrantStock Option (Right to Buy) · Derivative 170,250 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038203 · doc4.xml · derivative · entry 4

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,250

Underlying: Common Stock · 170,250 shares

Expires 2028-06-13

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:21 UTC
STACK DAVID MDirector · CEO and Chairman
GrantCommon Stock 28,375 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038203 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,415

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:17 UTC
PACE GARY WDirector
GrantStock Option (Right to Buy) · Derivative 4,693 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038197 · doc4.xml · derivative · entry 2

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,693

Underlying: Common Stock · 4,693 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:17 UTC
PACE GARY WDirector
GrantCommon Stock 782 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038197 · doc4.xml · nonDerivative · entry 1

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,319

F1 · shares: Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:14 UTC GrantStock Option (Right to Buy) · Derivative 4,693 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038193 · doc4.xml · derivative · entry 2

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,693

Underlying: Common Stock · 4,693 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:14 UTC GrantCommon Stock 782 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038193 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,529

F1 · shares: Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:12 UTC
Brege LauraDirector
GrantStock Option (Right to Buy) · Derivative 4,693 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038189 · doc4.xml · derivative · entry 2

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,693

Underlying: Common Stock · 4,693 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:12 UTC
Brege LauraDirector
GrantCommon Stock 782 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038189 · doc4.xml · nonDerivative · entry 1

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,627

F1 · shares: Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:20 UTC
RIKER LAURENVice President, Finance
GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038201 · doc4.xml · derivative · entry 2

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:20 UTC
RIKER LAURENVice President, Finance
GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038201 · doc4.xml · nonDerivative · entry 1

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,141

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:16 UTC GrantStock Option (Right to Buy) · Derivative 4,693 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038195 · doc4.xml · derivative · entry 2

Kronenfeld Mark A. · CIK 0001578074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,693

Underlying: Common Stock · 4,693 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:16 UTC GrantCommon Stock 782 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038195 · doc4.xml · nonDerivative · entry 1

Kronenfeld Mark A. · CIK 0001578074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,577

F1 · shares: Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:18 UTC
LARANJEIRA CHARLES ANTHONYSVP, Technical Operations
GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-18-038198 · doc4.xml · derivative · entry 2

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · SVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2028-06-13

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 23:18 UTC
LARANJEIRA CHARLES ANTHONYSVP, Technical Operations
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038198 · doc4.xml · nonDerivative · entry 1

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · SVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,238

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 07, 2018 Filed Jun 8, 2018 17:03 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 2,600 $37.53 $97,578.00
Disclosure

SEC source: 0001209191-18-036719 · doc4.xml · nonDerivative · entry 3

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,040

F2 · kind: These sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.25 to $37.95, inclusive.

Read SEC document
June 07, 2018 Filed Jun 8, 2018 17:03 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 7,191 $36.63 $263,406.33
Disclosure

SEC source: 0001209191-18-036719 · doc4.xml · nonDerivative · entry 2

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,640

F2 · kind: These sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $37.15, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4.

Read SEC document
June 06, 2018 Filed Jun 8, 2018 17:03 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 8,615 $35.61 $306,780.15
Disclosure

SEC source: 0001209191-18-036719 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,831

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:09 UTC
Scranton RichardChief Scientific Officer
SaleCommon Stock 1,367 $33.02 $45,138.34
Disclosure

SEC source: 0001209191-18-036184 · doc4.xml · nonDerivative · entry 1

Scranton Richard · CIK 0001709330 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,226

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:11 UTC
Weiland Robert J.Chief Commercial Officer
SaleCommon Stock 373 $33.02 $12,316.46
Disclosure

SEC source: 0001209191-18-036185 · doc4.xml · nonDerivative · entry 1

Weiland Robert J. · CIK 0001670648 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,088

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 339 and 258 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017 and December 2017, respectively.

Read SEC document
June 04, 2018 Filed Jun 6, 2018 20:08 UTC
Reinhart Charles A. IIIChief Financial Officer
SaleCommon Stock 708 $33.02 $23,378.16
Disclosure

SEC source: 0001209191-18-036182 · doc4.xml · nonDerivative · entry 1

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,042

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 04, 2018 Filed Jun 7, 2018 00:11 UTC
WILLIAMS KRISTENCAO and General Counsel
SaleCommon Stock 2,040 $33.02 $67,360.80
Disclosure

SEC source: 0001209191-18-036186 · doc4.xml · nonDerivative · entry 1

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,272

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 04, 2018 Filed Jun 7, 2018 00:07 UTC SaleCommon Stock 771 $33.90 $26,136.90
Disclosure

SEC source: 0001209191-18-036181 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,747

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 04, 2018 Filed Jun 7, 2018 00:09 UTC
RIKER LAURENVice President, Finance
SaleCommon Stock 801 $33.02 $26,449.02
Disclosure

SEC source: 0001209191-18-036183 · doc4.xml · nonDerivative · entry 1

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,641

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
May 15, 2018 Filed May 17, 2018 19:17 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $10.81 $0.00
Disclosure

SEC source: 0001209191-18-031185 · doc4.xml · derivative · entry 8

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,481

Underlying: Common Stock · 10,000 shares

Expires 2022-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option vested as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.

F7 · balance_after: Reflects the transfer of stock options to purchase 23,481 shares of common stock previously held indirectly by the reporting person through LCK Investment LLC to the reporting person directly.

Read SEC document
May 15, 2018 Filed May 17, 2018 19:17 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $5.49 $0.00
Disclosure

SEC source: 0001209191-18-031185 · doc4.xml · derivative · entry 7

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 610

Underlying: Common Stock · 15,000 shares

Expires 2020-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option vested as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.

Read SEC document
May 15, 2018 Filed May 17, 2018 19:17 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 3,894 $34.34 $133,719.96
Disclosure

SEC source: 0001209191-18-031185 · doc4.xml · nonDerivative · entry 4

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,446

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.10 to $34.90, inclusive.

Read SEC document
May 15, 2018 Filed May 17, 2018 19:17 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 21,106 $33.69 $711,061.14
Disclosure

SEC source: 0001209191-18-031185 · doc4.xml · nonDerivative · entry 3

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,340

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $34.08, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.

Read SEC document
May 15, 2018 Filed May 17, 2018 19:17 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 10,000 $10.81 $108,100.00
Disclosure

SEC source: 0001209191-18-031185 · doc4.xml · nonDerivative · entry 2

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,446

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
May 15, 2018 Filed May 17, 2018 19:17 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 15,000 $5.49 $82,350.00
Disclosure

SEC source: 0001209191-18-031185 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,446

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
May 02, 2018 Filed May 4, 2018 18:51 UTC
Scranton RichardChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $34.38 $0.00
Disclosure

SEC source: 0001209191-18-028188 · doc4.xml · derivative · entry 1

Scranton Richard · CIK 0001709330 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2028-05-02

F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
January 10, 2018 Filed Jan 12, 2018 18:15 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 28,885 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001209191-18-003469 · doc4.xml · derivative · entry 7

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,190

Underlying: Common Stock · 28,885 shares

Expires 2020-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months.

Read SEC document
January 10, 2018 Filed Jan 12, 2018 18:15 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 885 $41.97 $37,143.45
Disclosure

SEC source: 0001209191-18-003469 · doc4.xml · nonDerivative · entry 4

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,446

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.70 to $42.25, inclusive.

Read SEC document
January 10, 2018 Filed Jan 12, 2018 18:15 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 4,628 $41.03 $189,886.84
Disclosure

SEC source: 0001209191-18-003469 · doc4.xml · nonDerivative · entry 3

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,331

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.65 to $41.55, inclusive.

Read SEC document
January 10, 2018 Filed Jan 12, 2018 18:15 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 23,372 $39.96 $933,945.12
Disclosure

SEC source: 0001209191-18-003469 · doc4.xml · nonDerivative · entry 2

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,959

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.625 to $40.60, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4.

Read SEC document
January 10, 2018 Filed Jan 12, 2018 18:15 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 28,885 $1.61 $46,504.85
Disclosure

SEC source: 0001209191-18-003469 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · balance_after: Includes 167 shares of common stock acquired under the issuer's employee stock purchase plan in December 2017.

Read SEC document
January 03, 2018 Filed Jan 6, 2018 00:47 UTC
Braunstein ScottChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $46.35 $0.00
Disclosure

SEC source: 0001209191-18-002576 · doc4.xml · derivative · entry 1

Braunstein Scott · CIK 0001643875 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2028-01-03

F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.